Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saik Urien

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Antimicrobial Agents and Chemotherapy|October 20, 2010
Population pharmacokinetics of nevirapine in HIV-1-infected pregnant women and their neonatesSihem Benaboud, Didier K Ekouévi, Saik Urien, et al.
Antimicrobial Agents and Chemotherapy|December 24, 2008
Population pharmacokinetics of emtricitabine in human immunodeficiency virus type 1-infected pregnant women and their neonatesDéborah Hirt, Saik Urien, Elisabeth Rey, et al.
Seminars in Arthritis and Rheumatism|November 7, 2018
Etanercept concentration and immunogenicity do not influence the response to Etanercept in patients with juvenile idiopathic arthritisBrigitte Bader-Meunier, Roman Krzysiek, Irène Lemelle, et al.
Cancer|June 8, 2012
Safety, pharmacokinetics, and activity of EZN-2208, a novel conjugate of polyethylene glycol and SN38, in patients with advanced malignanciesRazelle Kurzrock, Sanjay Goel, Jennifer Wheler, et al.
British Journal of Clinical Pharmacology|November 1, 2015
Prediction of human fetal pharmacokinetics using ex vivo human placenta perfusion studies and physiologically based modelsMaïlys De Sousa Mendes, Deborah Hirt, Cécile Vinot, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 11, 2017
Assessment of Nevirapine Prophylactic and Therapeutic Dosing Regimens for NeonatesTim R Cressey, Baralee Punyawudho, Sophie Le Coeur, et al.
Therapie|February 9, 2021
Pharmacokinetics and pharmacodynamics of hydroxychloroquine in hospitalized patients with COVID-19Noël Zahr, Saik Urien, Benoit Llopis, et al.
Antiviral Therapy|April 29, 2022
Comparison of three galenic forms of lamivudine in young West African children living with Human Immunodeficiency VirusClaire Pressiat, Evelyne Dainguy, Jean-Marc Tréluyer, et al.
American Journal of Hematology|July 24, 2023
Systemic complement activation influences outcomes after allogeneic hematopoietic cell transplantation: A prospective French multicenter trialAnne Béatrice Notarantonio, Maud D'aveni-Piney, Simona Pagliuca, et al.
Annals of the Rheumatic Diseases|July 12, 2022
Management and outcome of native joint septic arthritis: a nationwide survey in French rheumatology departments, 2016-2017Pauline Richebé, Guillaume Coiffier, Pascal Guggenbuhl, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Antimicrobial Agents and Chemotherapy|October 20, 2010
Population pharmacokinetics of nevirapine in HIV-1-infected pregnant women and their neonatesSihem Benaboud, Didier K Ekouévi, Saik Urien, et al.
Antimicrobial Agents and Chemotherapy|December 24, 2008
Population pharmacokinetics of emtricitabine in human immunodeficiency virus type 1-infected pregnant women and their neonatesDéborah Hirt, Saik Urien, Elisabeth Rey, et al.
Seminars in Arthritis and Rheumatism|November 7, 2018
Etanercept concentration and immunogenicity do not influence the response to Etanercept in patients with juvenile idiopathic arthritisBrigitte Bader-Meunier, Roman Krzysiek, Irène Lemelle, et al.
Cancer|June 8, 2012
Safety, pharmacokinetics, and activity of EZN-2208, a novel conjugate of polyethylene glycol and SN38, in patients with advanced malignanciesRazelle Kurzrock, Sanjay Goel, Jennifer Wheler, et al.
British Journal of Clinical Pharmacology|November 1, 2015
Prediction of human fetal pharmacokinetics using ex vivo human placenta perfusion studies and physiologically based modelsMaïlys De Sousa Mendes, Deborah Hirt, Cécile Vinot, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 11, 2017
Assessment of Nevirapine Prophylactic and Therapeutic Dosing Regimens for NeonatesTim R Cressey, Baralee Punyawudho, Sophie Le Coeur, et al.
Therapie|February 9, 2021
Pharmacokinetics and pharmacodynamics of hydroxychloroquine in hospitalized patients with COVID-19Noël Zahr, Saik Urien, Benoit Llopis, et al.
Antiviral Therapy|April 29, 2022
Comparison of three galenic forms of lamivudine in young West African children living with Human Immunodeficiency VirusClaire Pressiat, Evelyne Dainguy, Jean-Marc Tréluyer, et al.
American Journal of Hematology|July 24, 2023
Systemic complement activation influences outcomes after allogeneic hematopoietic cell transplantation: A prospective French multicenter trialAnne Béatrice Notarantonio, Maud D'aveni-Piney, Simona Pagliuca, et al.
Annals of the Rheumatic Diseases|July 12, 2022
Management and outcome of native joint septic arthritis: a nationwide survey in French rheumatology departments, 2016-2017Pauline Richebé, Guillaume Coiffier, Pascal Guggenbuhl, et al.
Pageof 7